Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free NVO Stock Alerts $126.93 +1.14 (+0.91%) (As of 03:28 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Novo Nordisk A/S Short Interest DataCurrent Short Volume3,240,000 sharesPrevious Short Volume2,830,000 sharesChange Vs. Previous Month+14.49%Dollar Volume Sold Short$401.27 millionShort Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares4,487,530,000 sharesPercentage of Shares Shorted0.07%Today's Trading Volume2,692,340 sharesAverage Trading Volume4,789,923 sharesToday's Volume Vs. Average56% Short Selling Novo Nordisk A/S ? Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNVO Short Interest Over TimeNVO Days to Cover Over TimeNVO Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Novo Nordisk A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85 3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40 3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35 2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74 2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72 1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69 Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16 12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45 12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07 11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85 11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42 10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57 10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14 9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94 9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60 8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72 8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12 7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10 7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14 6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83 6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53 5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50 5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43 4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09 4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60 3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14 3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98 2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99 2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96 1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78 1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32 12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34 12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68 11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60 11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64 10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84 10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80 9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63 9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21 8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. NVO Short Interest - Frequently Asked Questions What is Novo Nordisk A/S's current short interest? Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,240,000 shares of NVO short. Learn More on Novo Nordisk A/S's current short interest. What is a good short interest ratio for Novo Nordisk A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 1.0. Learn More on Novo Nordisk A/S's short interest ratio. Which institutional investors are shorting Novo Nordisk A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novo Nordisk A/S: IMC Chicago LLC, Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Capital Fund Management S.A., Optiver Holding B.V., Kopernik Global Investors LLC, IMC Chicago LLC, Guardian Capital LP, Concourse Financial Group Securities Inc., and Genus Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Novo Nordisk A/S's short interest increasing or decreasing? Novo Nordisk A/S saw a increase in short interest in April. As of April 15th, there was short interest totaling 3,240,000 shares, an increase of 14.5% from the previous total of 2,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Novo Nordisk A/S's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Novo Nordisk A/S: Eli Lilly and Company (0.65%), Johnson & Johnson (0.69%), Merck & Co., Inc. (0.81%), AbbVie Inc. (0.76%), AstraZeneca PLC (0.28%), Novartis AG (0.19%), Abbott Laboratories (0.75%), Pfizer Inc. (1.20%), UnitedHealth Group Incorporated (0.86%), Thermo Fisher Scientific Inc. (0.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Novo Nordisk A/S stock? Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading up $1.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novo Nordisk A/S? A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further. How often is Novo Nordisk A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Eli Lilly and Company Short Squeeze Johnson & Johnson Short Squeeze Merck & Co., Inc. Short Squeeze AbbVie Short Squeeze AstraZeneca Short Squeeze Novartis Short Squeeze Abbott Laboratories Short Squeeze Pfizer Short Squeeze UnitedHealth Group Short Squeeze Thermo Fisher Scientific Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NVO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold